PG
PBYI icon

PEAK6 Group’s Puma Biotechnology PBYI Stock Holding History

PEAK6 Group’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-38,893
Closed -$3.05M – 5163
2015
Q3 		$2.93M Sell
38,893
-2,740
-7% -$259K 0.02% 1273
2015
Q2 		$4.86M Buy
41,633
+38,116
+1,084% +$6.9M 0.03% 857
2015
Q1 		$830K Buy
3,517
+2,598
+283% +$555K 0.01% 2075
2014
Q4 		$174K Buy
+919
New +$204K ﹤0.01% 3472

Other funds holding PBYI

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $44.4B AUM 36.05% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

PEAK6 Group's PBYI Position: Q4 2015 in Review

PEAK6 Group sold out of Puma Biotechnology (PBYI) in Q4 2015, closing a stake of 38,893 shares — an estimated $3.05M sold.

PEAK6 Group first reported a position in PBYI in Q4 2014 and held it in 4 quarters. The position peaked at $4.86M in Q2 2015. 133 funds tracked by Wall St. Rank hold PBYI as of Q4 2015.

  • PEAK6 Group reported no remaining Puma Biotechnology position as of Q4 2015 after selling out during the quarter.
  • PEAK6 Group sold 38,893 Puma Biotechnology shares in Q4 2015, an estimated $3.05M.
  • PEAK6 Group first reported a position in Puma Biotechnology in Q4 2014 and held it in 4 quarters.
  • PEAK6 Group's Puma Biotechnology position peaked at $4.86M in Q2 2015.
  • 133 funds tracked by Wall St. Rank held Puma Biotechnology as of Q4 2015.

Based on PEAK6 Group's 13F filing for Q4 2015, filed 16 Feb 2016.